| 6,021 | 280 | 89 |
| 下载次数 | 被引频次 | 阅读次数 |
右美托咪定是高效、高选择性的肾上腺素α2受体激动药,具有镇痛作用和剂量依赖性镇静作用。右美托咪定可单独应用,也可与咪达唑仑、丙泊酚或阿片类药物合用,对呼吸抑制作用小。右美托咪定已在辅助检查、各科手术、ICU等临床领域应用,具有良好的镇静、镇痛效果,且可减少常规镇痛药和镇静药的用量,与其他麻醉、镇痛、镇静药物没有配伍禁忌。本文综述了右美托咪定的药效学、药动学,以及临床研究、药物经济学等方面的研究新进展。
Abstract：Dexmedetomidine is a strong potent and highly selectiveα2-adrenergic receptor agonist. Clinical practices demonstrate that it has sedative as well as analgesia effects and dosages dependence.It can be used alone or combined with midazolam,propofol or opioids resulting in decreasing the needs of other sedatives and analgesic drugs.Dexmedetomidine has been used in many clinical fields,such as anxiliary examination, various surgeries,ICU etc.,with good sedative and analgesic effect.It has no incompatibility with other anesthesia,analgesic and sedative drugs.The progresses of dexmedetomidine,such as pharmacodynamics, pharmacokinetics,indications,recent clinical trials and pharmacoeconomics,are reviewed in this paper.
[1]中华医学会重症医学分会.重症加强治疗病房病人镇痛和镇静治疗指南[J].中国实用外科杂志,2006,26(12):893-901.
[2]汤文喜,孙运波.右美托咪定:值得期待的重症监护病房的镇静药[J].中国新药与临床杂志.2008,27(4):296-299
[3]GUO TZ,POREE L,GOLDEN WJ,et al.Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat[J],Anesthesiology,1996,85 (4):846-852.
[4]NELSON LE,LU J,GUO T,et al.The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleeppromoting pathway to exert its sedative effects[J].Anesthesiology, 2003,98(2):428-436.
[5]KENDIG JJ,SAVOLA MK,WOODLEY SJ,et al.Alpha 2- adrenoceptors inhibit a nociceptive response in neonatal rat spinal cord[J].Eur J Pharmacol,1991,192(2):293-300.
[6]LAKHLANI PP,MacMILLAN LB,GUO TZ,et al.Subslitution of a mutant alpha2a-adrenergie receptor via "hit and run"gene targeting reveals the role of this subtype in sedative,analgesic, and anesthetic-sparing responses in vivo[J].Proc Natl Acad Sci, 1997,94(18):9950-9955.
[7]POREE LR,GUO TZ,KINGEKY WS,et al.The analgesic potency of dexmedetomidine is enhanced after nerve injury:a possible role for peripheral alpha2-adrenoceptors[J].Anesth Analg, 1998,87(4):941-948.
[8]BHANA N,GOA KL,McCLELLAN KJ.Dexmedetomidine[J]. Drugs,2000,59(2):263-270.
[9]JAAKOLA ML,ALI-MELKKILA TA,KANTO A,et al.Dexmedetomidine reduces intraocular pressure,intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery[J].Br J Anaesth,1992,68(6):570-575.
[10]LAWRENCE CJ,de LANGE S.Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and perioperative haemodynamic stability[J].Anaesthesia,1997,52(8): 736-744.
[11]TALKE P,CHEN R,THOMAS B,et al.The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery[J].Anesth Analg,2000,90(4):834-839.
[12]WIJEYSUNDERA DN.NAIK JS,BEATTIE WS.Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis[J].Am J Med,2003,114(9):742- 752.
[13]SOUTER MJ,ROZET I.OJEMANN JG,et al.Dexmedetomidine sedation during awake craniotomy for seizure resection:effects on electrocorticography[J].J Neurosurg Anesthesiol,2007,19 (1):38-44.
[14]李彦文.盐酸右美托咪定在国人体内的临床药动学和药效学研究[D].中南大学,2008年
[15]de WOLF AM,FRAGEN RJ,A VRAM MJ.et al.The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment[J].Anesth Analg,2001,93(5):1205-1209.
[16]ABOUZGHEIB WB,L1TTMAN J,PRATTER M.et al.Efficacy and safety of dexmedetomidine during bronchoscopy in patients with moderate to severe GOPD or emphysema[J].J Bronchol, 2007,14(4):233-236.
[17]DEMIRARAN Y,KORKUT E,TAMER A,et al.The comparison of dexmedetomidine and midazolam used for sedation of patients during upper endoscopy:A prospective,randomized study [J].Can J Gastroenterol,2007,21(1):25-29.
[18]MASON KP,ZURAKOWSKI D,ZGLESZEWSKl SE,et al.High dose dexmedetomidine as the sole sedative for pediatric MRI[J], Paediatr Anaesth,2008,18(5):403-411.
[19]KOROGLU A,TEKSAN H,SAGIR 0,et al.A comparison of the sedative,hemodynamic,and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging[J].Anesth Analg,2006,103(1):63-67.
[20]PLUNKETT AR,SHIELDS C,STOJADINOVIC A,et al.Awake thyroidectomy under local anesthesia and dexmedetomidine infusion[J].Mil Med,2009,174(1):100-102.
[21]MANDEL JE,TANNER JW.LICHTENSTEIN GR,et al.A randomized,controlled,double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy[J].Anesth Analg,2008,102(2):434-439.
[22]KAYA FN,YAVASCAOGLU B,TURKER G,et al.Intravenous dexmedetomidine,but not midazolam,prolongs bupiva-caine spinal anesthesia[J].Can J Anaesth,2010,57(1):39-45.
[23]CHU KS,WANG FY,HSU HT,el al.The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation[J].Eur J Anaesthesiol, 2010,27(1):36-40.
[24]MENDA F,KONER O,SAYIN M,et al.Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fastrack CABG[J].Ann Card Anaesth,2010,13(1):16-21.
[25]SHEHABI Y,GRANT P,WOLFENDEN H,et al.Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery:a randomized controlled trial(DEX-medetomidine Compared to Morphine-DEXCOM Study)[J]. Anesthesiology,2009,111(5):1075-1084.
[26]MARTIN E,RAMSAY G,MANTZ J,et al.The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit[J].J Intensive Care Med,2003, 18(1):29-41.
[27]GERLACH AT,DASTA JF.Dexmedetomidine:an updated review [J].Ann Pharmacother,2007,41(2):245-252.
[28]RIKER RR,SHEHABI Y,BOKESCH PM,et al.Dexmedetomidine vs midazolam for sedation of critically ill patients:a randomized trial[J].JAMA,2009,301(5):489-499.
[29]MALDONADO JR,WYSONG A,van der STARRE PJ,et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery[J].Psychosomatics,2009,50(3):206- 217.
[30]WUNSCH H,KRESS JP,A new era for sedation in ICU patients [J].JAMA,2009.301(5):542-544.
[31]NUNES RR,CAVALCANTE SL.Influence of dexmedetomidine upon sevoflurane end-expiratory concentration.Evaluation by bispectral index,suppression rate and electroencephalographic power spectral analysis[J].Rev Bras Anestesiol,2002,52(2):133- 145.
[32]SIOBAL MS,KALLET RH,KIVETT VA,et al.Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation:a pilot study[J].Respir Care, 2006,51(5):492-496.
[33]ARPINO PA,KALAFATAS K,THOMPSON BT,Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit[J].J Clin Pharm Ther,2008,33(1 ):25-30.
[34]CORBETT SM,REBUCK JA,GREENE CM,et al.Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation[J].Crit Care Med, 2005,33(5):940-945.
[35]RUOKONEN E,PARVIAINEN I,JAKOB SM,et al.Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical venlilation[J],Intensive Care Med,2009,35 (2):282-290.
[36]MacLARENR,FORREST LK,KISER TH.Adjunctive dexmedetomidine therapy in the intensive care unit:a retrospective assessment of impact on sedative and analgesic requirements,levels of sedation and analgesia,and ventilatory and hemodynamic parameters[J]. Pharmacotherapy,2007,27(3):351-359.
[37]LIN TF,YEH YC,LIN FS,et al.Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia [J].Br J Anaesth,2009,102(1):117-122.
[38]贺志飚,柴湘平,周卜邻.右美托咪啶治疗苯丙胺类药物急性中毒的疗效初探[J].中南药学.2010,8(4):304-307.
[39]DASTA JF,JACOBI J,SESTI AM,et al.Addition of dexmedetomidine to standard sedation regimens after cardiac surgery:an outcomes analysis[J].Pharmacotherapy,2006,26(6):798-805.
[40]DASTA JF,KANE-GILL SL.PENCINA M,et al.A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit[J].Crit Care Med,2010,38(2):497-503.
基本信息:
中图分类号:R971
引用信息:
[1]易利丹,彭六保,谭重庆,等.新型镇静镇痛药——右美托咪定[J].中国新药与临床杂志,2011,30(01):5-10.
基金信息:
湖南省科技厅课题(2008ZK3039)
2011-01-25
2011-01-25